AGL agilon health, inc.
company
SEC Filings & Insider Trading Activity 2026

CIK: 1831097
Health Care
Services-Misc Health & Allied Services, NEC 26 filings
Russell 2000

Latest agilon health, inc. (AGL) SEC EDGAR filings in 2026 — including the most recent 10-K annual report filed on February 25, 2026, a 10-Q quarterly report filed on November 4, 2025, an 8-K current report filed on April 27, 2026. SignalX aggregates every new 10-K annual report, 10-Q quarterly report, 8-K current report, and Form 4 insider transaction for agilon health, inc. (AGL) (SEC CIK 1831097), with AI-powered section-by-section summaries updated daily.

10-Q: 15
8-K: 6
10-K: 5

Latest 2026 SEC Filing Dates

10-K Annual Report
Feb 25, 2026
10-Q Quarterly Report
Nov 4, 2025
8-K Current Report
Apr 27, 2026

AI 8-K Current Report Analysis
Recent 8-K Filings

Filed Mar 18, 2026
8-K
Full analysis →

Item 5.07: Submission of Matters to a Vote of Security Holders

  • Stockholders approved reverse stock split amendment, ratio range 1-for-5 to 1-for-25, enabling Board to set final ratio within this range
  • Reverse split does not reduce authorized common stock shares, preserving share capital flexibility

Item 8.01: Other Events

  • Board approved 1-for-25 reverse stock split of Common Stock, effective March 30, 2026 at 5:00 p.m. ET
  • Reverse split aims to increase per-share price, potentially restoring compliance with exchange listing requirements

Recent 8-K Filings
Current Reports

AI-powered analysis of agilon health, inc. (AGL) 8-K current reports disclosing material events.

Latest 2026 SEC Filings — 10-K, 10-Q, 8-K & Form 4

FormFiling DatePeriodAnalysisSEC
8-K
Apr 27, 2026
8-K
Mar 30, 2026
8-K
Mar 18, 2026Analysis
8-K
Feb 25, 2026Analysis
10-K
Feb 25, 2026Dec 31, 2025
8-K
Feb 12, 2026
8-K
Jan 7, 2026
10-Q
Nov 4, 2025Sep 30, 2025
10-Q
Aug 4, 2025Jun 30, 2025
10-Q
May 6, 2025Mar 31, 2025
10-K
Feb 25, 2025Dec 31, 2024
10-Q
Nov 7, 2024Sep 30, 2024
10-Q
Aug 6, 2024Jun 30, 2024
10-Q
May 7, 2024Mar 31, 2024
10-K
Feb 27, 2024Dec 31, 2023
10-Q
Nov 2, 2023Sep 30, 2023
10-Q
Aug 3, 2023Jun 30, 2023
10-Q
May 9, 2023Mar 31, 2023
10-K
Mar 1, 2023Dec 31, 2022
10-Q
Nov 3, 2022Sep 30, 2022
10-Q
Aug 4, 2022Jun 30, 2022
10-Q
May 5, 2022Mar 31, 2022
10-K
Mar 3, 2022Dec 31, 2021
10-Q
Oct 28, 2021Sep 30, 2021
10-Q
Aug 4, 2021Jun 30, 2021

Frequently Asked Questions

What are the latest AGL SEC filings in 2026?

agilon health, inc. (AGL) has filed a 10-K annual report on February 25, 2026, a 10-Q quarterly report on November 4, 2025, an 8-K current report on April 27, 2026 with the SEC. SignalX tracks every new SEC EDGAR filing daily, including 10-K, 10-Q, 8-K, and Form 4 insider transactions, with AI-powered summaries of key sections.

When did AGL file its most recent 10-K annual report?

agilon health, inc. (AGL) filed its most recent 10-K annual report on February 25, 2026. The 10-K includes audited financial statements, business overview, risk factors, and management discussion, all available on SignalX with AI-generated summaries and XBRL financial data.

How do I view AGL 10-Q quarterly reports?

agilon health, inc. (AGL)'s most recent 10-Q quarterly report was filed on November 4, 2025. SignalX displays every AGL 10-Q with AI-generated summaries of the MD&A (Management Discussion & Analysis) and Risk Factors sections, plus links to the original SEC EDGAR document.

What 8-K current reports has AGL filed recently?

agilon health, inc. (AGL)'s most recent 8-K was filed on April 27, 2026. 8-K filings disclose material corporate events such as earnings releases, executive changes, mergers, and other significant developments. SignalX surfaces each 8-K with item-level summaries so you can quickly see what happened.

Where can I find AGL insider trading activity (Form 4)?

SignalX aggregates every AGL Form 4 insider transaction from SEC EDGAR. Form 4 reports show when officers, directors, and 10% shareholders buy or sell company stock, with transaction code, share count, and price per share.

How often does AGL file with the SEC?

agilon health, inc. (AGL) files a 10-K annual report once per year (typically within 60 days of fiscal year-end) and 10-Q quarterly reports three times per year. 8-K current reports are filed as needed when material events occur, and Form 4 insider transaction reports are due within two business days of a trade. SignalX monitors SEC EDGAR daily to surface every new AGL filing with AI-powered analysis.

What is the difference between 10-K, 10-Q, and 8-K SEC filings?

A 10-K is a comprehensive annual report with audited financials, business overview, and risk factors. A 10-Q is a shorter quarterly report with unaudited financials and management discussion. An 8-K is a current report filed when a material event occurs — such as earnings releases, executive changes, acquisitions, or other significant developments. SignalX provides AI-generated summaries for all three filing types for agilon health, inc. (AGL).

What is AGL's SEC CIK number?

agilon health, inc. (AGL)'s SEC CIK (Central Index Key) number is 1831097. The CIK is a unique identifier assigned by the SEC to every filing entity. You can use CIK 1831097 to look up all AGL filings on SEC EDGAR, or browse them here on SignalX with AI-powered analysis.

Where can I find AGL return on equity (ROE) and financial data?

SignalX extracts XBRL financial data from agilon health, inc. (AGL) 10-K annual filings, including revenue, net income, gross profit, operating income, EPS, total assets, stockholders' equity, and operating cash flow. Return on equity (ROE) can be derived from net income divided by stockholders' equity. Multi-year financial trends are displayed in the Financial Summary table above.

Stay on top of agilon health, inc. SEC filings

Insider trading data, fund holdings, cross-signal detection, and AI-powered analysis for 26+ filings.